Use of yttrium-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports
Y-90 radioembolization achieves durable hepatic response in rare pancreatic exocrine malignancies with a favorable safety profile.
Authors
- Christine Alewine (ORCID: https://orcid.org/0000-0003-1661-0957)
- Charles Nutting (ORCID: https://orcid.org/0000-0002-4254-7405)
- David Sperling
- Nebojša Skorupan (ORCID: https://orcid.org/0000-0003-0854-3360)
- Allen Lee Cohn
- Markku Miettinen
Institutions
- Dartmouth College (US)
- National Institutes of Health (US)
- Memorial Sloan Kettering Cancer Center (US)
- Tri-County Health Department (US)
- Dartmouth Psychiatric Research Center (US)
- Rocky Mountain Cancer Centers (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Guided Therapeutics (United States) (US)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2026-02-10
- DOI
- https://doi.org/10.3748/wjg.v32.i8.113861
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00